Buy Stocks Easy | About Us
August 18, 2022
Buy Stocks Easy | Online Stocks

SELB


Buy Selecta Biosciences, Inc. Stock (symbol: SELB) Easy Online

Company Name: Selecta Biosciences, Inc.

Symbol: SELB

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2016

SELB Current Share Price

Today's SELB ( Selecta Biosciences, Inc. ) opening price: $

Yesterday's SELB ( Selecta Biosciences, Inc. ) closing price: $

Selecta Biosciences, Inc. Stock ( symbol: SELB ) Price Chart since IPO (2016):

12 Months Selecta Biosciences, Inc. Stock ( symbol: SELB ) Price Chart

Popular Questions about Selecta Biosciences, Inc. Public Stock ( SELB )

A: Selecta Biosciences, Inc. stock symbol (also called stock or share ticker) is SELB

A: Selecta Biosciences, Inc. IPO (Initial Public Offering) took place on 2016

A: Selecta Biosciences, Inc.'s stock (SELB symbol) price at ther IPO (initial Public Offering) was $

Q: Is SELB stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Selecta Biosciences, Inc. stock (symbol: SELB) at the beginning of 2019, at the opening share price of $1.5700, with a minimum of $200, by now your shares would be worth $25676 and your profit would be $25476 - SHOW ONLY IF PROFIT.

Buy Selecta Biosciences, Inc. Stock Easy Online

Selecta Biosciences, Inc. Stock Ticker Price Chart since IPO:





Selecta Biosciences, Inc. Stock Price Yesterday



 


Selecta Biosciences, Inc. Stock Price – Last Week




 


Selecta Biosciences, Inc. Stock Price – Last Month




 


Selecta Biosciences, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1962799/0/en/AskBio-Licenses-Rights-to-Selecta-Biosciences-ImmTOR-Immune-Tolerance-Platform-for-the-Treatment-of-Pompe-Disease.html
                            

                                
AskBio Licenses Rights to Selecta Biosciences’ ImmTOR™ Immune Tolerance Platform for the Treatment of Pompe Disease

                                
                                
– Selecta eligible to receive upfront and milestone payments of ove...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1962796/0/en/Selecta-Biosciences-Announces-Completion-of-Enrollment-in-Head-to-Head-COMPARE-Trial-of-SEL-212.html
                            

                                
Selecta Biosciences Announces Completion of Enrollment in Head-to-Head COMPARE Trial of SEL-212

                                
                                
– Top-line statistical results expected mid-2020 –


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/19/1962786/0/en/Selecta-Biosciences-Announces-70-Million-Private-Placement.html
                            

                                
Selecta Biosciences Announces $70 Million Private Placement

                                
                                
WATERTOWN, Mass., Dec.  19, 2019  (GLOBE NEWSWIRE) --  Selecta Bios...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/21/1950726/0/en/Selecta-Biosciences-Appoints-Carrie-S-Cox-as-Chairman-of-its-Board-of-Directors.html
                            

                                
Selecta Biosciences Appoints Carrie S. Cox as Chairman of its Board of Directors

                                
                                
– Former Chairman, CEO, and senior executive at numerous biotechnol...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/12/1945305/0/en/Selecta-Biosciences-to-Present-at-the-Stifel-2019-Healthcare-Conference.html
                            

                                
Selecta Biosciences to Present at the Stifel 2019 Healthcare Conference

                                
                                
WATERTOWN, Mass., Nov.  12, 2019  (GLOBE NEWSWIRE) -- Selecta Biosc...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305550-selecta-biosciences-inc-selb-ceo-carsten-brunn-q3-2019-results-earnings-call-transcript
                            

                                
Selecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q3 2019 Results - Earnings Call Transcript

                                
                                
Selecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q3 2019 Resul...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/24/1934904/0/en/Selecta-Biosciences-to-Present-Phase-2-Data-for-SEL-212-in-Chronic-Refractory-Gout-at-Upcoming-2019-ACR-Annual-Meeting.html
                            

                                
Selecta Biosciences to Present Phase 2 Data for SEL-212 in Chronic Refractory Gout at Upcoming 2019 ACR Annual Meeting

                                
                                
WATERTOWN, Mass., Oct.  24, 2019  (GLOBE NEWSWIRE) --  Selecta Bios...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/23/1934223/0/en/Selecta-Biosciences-Presents-New-Preclinical-Data-from-its-Gene-Therapy-Program-at-2019-ESGCT-Annual-Congress.html
                            

                                
Selecta Biosciences Presents New Preclinical Data from its Gene Therapy Program at 2019 ESGCT Annual Congress

                                
                                
WATERTOWN, Mass., Oct.  23, 2019  (GLOBE NEWSWIRE) --  Selecta Bios...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4283619-selecta-biosciences-inc-selb-ceo-carsten-brunn-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts
                            

                                
Selecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q2 2019 Results - Earnings Call Transcript

                                
                                
Selecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q2 2019 Resul...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/432786/selecta-biosciences-sees-hammer-chart-pattern-time-to-buy
                            

                                
Selecta Biosciences Sees Hammer Chart Pattern: Time to Buy?

                                
                                
Selecta Biosciences has been struggling lately, but the selling pre...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.